- While presurgical eating behaviors have demonstrated limited prognostic value, cognitions regarding the effects of eating may serve as important predictors of weight loss outcomes after bariatric surgery. The Eating Expectancies Inventory (EEI) is a commonly used, self-report measure of expected consequences of eating; however, its psychometric and predictive properties have not yet been evaluated among bariatric surgery patients.
- Diabetes is an epidemic disease and is estimated to affect >300 million people worldwide in 2025 . Type 2 diabetes (T2D) management is a combination of diet, lifestyle modifications, and drug therapy. Recently, many studies have shown remission of T2D in obese population [2–6]. Buchwald et al.  in his systemic review and meta-analysis showed that diabetes remission rates were 99% (95% confidence interval, 97%–100%) after biliopancreatic diversion, 84% (95% confidence interval, 77%–90%) after Roux-en-Y gastric bypass (RYGB), and 48% (95% confidence interval, 29%–67%) after gastric banding.
- Obesity is the major trigger of nonalcoholic fatty liver disease (NAFLD). NAFLD is further favored by the patatin-like phospholipase domain-containing 3 (PNPLA3) p.I148M, transmembrane 6 superfamily member 2 (TM6SF2) p.E167K, and membrane-bound O-acyltransferase domain containing 7 (MBOAT7) rs641738 variants.
- Endoscopic treatment of obesity might be an alternative to surgical treatment or, preoperatively, serve as an auxiliary therapy to surgery in patients at increased surgical risk.
- Although the published data have clearly related the size of the gastrojejunostomy anastomosis to the subsequent likelihood of a stricture, a correlation between the anastomosis size and postoperative weight loss has not previously been described.